Patent · US Active

Use of 15-benzylidene-14-deoxy-11, 12-dehydroandrographolide derivative in manufacture of medicaments for protecting liver and anti-hepatitis C virus

US9388169B2 · kind B2 · utility

0Cited by

0References

5Claims

0Family size

Assignee

CHANGZHOU UNIVERSITY · CN

Inventors

Guifu Dai · Zhengzhou, CN
Songlin Zhu · Zhengzhou, CN
Yanan Wang · Hubei, CN
Jian WU · Zhengzhou, CN
Dan Zhao · Singapore, SG
Di Wu · Danbury, US
Huanfei Liu · Zhengzhou, CN
Haiwei Xu · Zhengzhou, CN
Mengjiao Liu · Zhengzhou, CN
Jing Zhao · Shanghai, CN
Wei Han · Beaverton, US
Zhenwei Wu · West Lafayette, US
Hang Wang · Wuxi, CN
Hongmin Liu · Zhengzhou, CN

Key dates

Filing date	Feb 5, 2013
Grant date	Jul 12, 2016
Priority date	—
Expiry date	Feb 5, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K47/38
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed is use of andrographolide derivative as shown by general formula 1 in manufacture of medicaments for anti-hepatitis C virus, and preventing and treating immunological liver damage caused by virus infection and different chemical liver damage.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.